- Home
- AARD vs FF Comparison
AARD vs FF Comparison
Compare AARD & FF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- FF
- Stock Information
- Founded
- AARD 2017
- FF N/A
- Country
- AARD United States
- FF United States
- Employees
- AARD N/A
- FF N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- FF Major Chemicals
- Sector
- AARD Health Care
- FF Industrials
- Exchange
- AARD Nasdaq
- FF Nasdaq
- Market Cap
- AARD 154.9M
- FF 172.1M
- IPO Year
- AARD 2025
- FF N/A
- Fundamental
- Price
- AARD $6.93
- FF $3.94
- Analyst Decision
- AARD Strong Buy
- FF Strong Buy
- Analyst Count
- AARD 4
- FF 1
- Target Price
- AARD $31.50
- FF $0.80
- AVG Volume (30 Days)
- AARD 129.3K
- FF 488.6K
- Earning Date
- AARD 01-01-0001
- FF 05-08-2025
- Dividend Yield
- AARD N/A
- FF 6.07%
- EPS Growth
- AARD N/A
- FF N/A
- EPS
- AARD N/A
- FF 0.35
- Revenue
- AARD N/A
- FF $243,339,000.00
- Revenue This Year
- AARD N/A
- FF N/A
- Revenue Next Year
- AARD N/A
- FF N/A
- P/E Ratio
- AARD N/A
- FF $11.26
- Revenue Growth
- AARD N/A
- FF N/A
- 52 Week Low
- AARD $4.88
- FF $3.77
- 52 Week High
- AARD $19.58
- FF $6.40
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- FF 42.20
- Support Level
- AARD N/A
- FF $3.87
- Resistance Level
- AARD N/A
- FF $4.05
- Average True Range (ATR)
- AARD 0.00
- FF 0.20
- MACD
- AARD 0.00
- FF 0.01
- Stochastic Oscillator
- AARD 0.00
- FF 37.78
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.